How can you maintain weight loss after stopping a GLP-1
Notably, Richard et al
GLP-3RT 30mg Retatrutide Research-Grade GLP-1/GIP Compound 99% Purity 43 in stock What is GLP-3RT
Triple Agonist vs Dual Agonist Comparison Contents Key Takeaways Two Compounds, One Manufacturer, Different Receptor Counts Weight Loss: The Numbers Side by Side Mechanism Breakdown: What the Third Receptor Adds Safety: Where the Tradeoffs Appear Evidence Quality: Phase 2 vs Phase 3 Where Each Compound Might Win The Bottom Line Explore Research Peptides Retatrutide 12mg 24.2% body weight lost (Phase 2, 48 wk) vs Tirzepatide 15mg 22.5% body weight lost (Phase 3, 72 wk) 3 vs 2 receptor targets (retatrutide vs tirzepatide) 63% vs 57% reached 20%+ weight loss (highest dose arms) Eli Lilly same manufacturer for both compounds Sources: Retatrutide Phase 2 (NEJM, 2023), SURMOUNT-1 (NEJM, 2022)
She has helped me and many others feel better about ourselves
Retatrutide vs Tirzepatide Dosage Both medications follow a gradual titration model, but each interacts with different metabolic receptors, which affects appetite, digestive speed, and overall weight-loss potential